TrialProceedings of the National Academy of Sciences of the United States of America2006

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

Elke Jäger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.